Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.77 USD | +3.19% | +4.00% | -23.36% |
31/05 | Ionis Reports 'Positive Results' From Studies of Investigational Treatment for Hereditary Angioedema | MT |
31/05 | Transcript : Ionis Pharmaceuticals, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.36% | 547.94Cr | |
+48.64% | 5.46TCr | |
-6.44% | 3.99TCr | |
+37.07% | 3.88TCr | |
+14.28% | 2.69TCr | |
-11.17% | 2.62TCr | |
-21.40% | 1.88TCr | |
+25.64% | 1.22TCr | |
+0.96% | 1.22TCr | |
+27.04% | 1.19TCr |
- Stock Market
- Equities
- IONS Stock
- News Ionis Pharmaceuticals, Inc.
- Transcript : Ionis Pharmaceuticals, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 10